The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•13 February 2026•

1 min read

Zacks Research Raises EPS Estimates for Synchrony Financial and HCA Healthcare

A man in a suit over a stock chart with 'Mondelez International' text, surrounded by chocolate, cocoa beans, factories, and shops.

Zacks Research has significantly upgraded its long-term earnings per share (EPS) estimates for Synchrony Financial (SYF) and HCA Healthcare (HCA) following robust quarterly performances. For Synchrony Financial, the research firm raised its FY2028 EPS projection to $11.11, a figure substantially higher than the market consensus of $7.67. This optimism follows Synchrony's strong fourth-quarter earnings of $2.18 per share and the authorization of a new $1.0 billion share buyback program. Similarly, HCA Healthcare saw its FY2026 EPS estimate increased to $29.31 after reporting a fourth-quarter beat with $8.01 per share against expected estimates. These upward revisions reflect growing analyst confidence in the fundamental growth trajectories and capital return strategies of both companies. The positive outlook is driven by strong management guidance and resilient operational performance across the financial and healthcare sectors.